Theramex SpA

5 articles about Theramex SpA

• Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

  10/10/2023

  Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, is pleased to announce that it has entered into an agreement to acquire the European rights to Duphaston® and Femoston® from Viatris Inc.

• Theramex Appoints Sigurd Kirk to the Board of Directors

  7/12/2021

  Theramex has announced that Sigurd (Sig) Kirk has been appointed as a member of the Board of Directors for Theramex.

• TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States

  6/7/2019

  TherapeuticsMD, Inc. announced that it has entered into an exclusive license and supply agreement with Theramex, a leading, global specialty pharmaceutical company dedicated to women’s health, to commercialize BIJUVA and IMVEXXY outside of the United States.

• Teva Pharmaceutical Industries Limited Completes Acquisition of Theramex SpA

  1/5/2011

• Teva Pharmaceutical Industries Limited to Acquire Theramex SpA, Merck KGaA’s European Based Women’s Health Business; Teva To Pay $367 Million at Closing

  10/28/2010